Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cetylated fatty acids (CFAs) are a group of naturally occurring fats formed by the esterification of fatty acids (such as myristoleic, myristic, oleic, palmitic acids) to cetyl alcohol. CFAs, and especially cetyl myristoleate, have been marketed and studied mainly as dietary supplements for joint health and inflammation reduction. Preclinical and limited clinical data suggest that oral or topical administration of CFAs may decrease levels of inflammatory cytokines, lubricate and stabilize cell membranes, enhance joint mobility, and promote chondrogenic differentiation in vitro. They are not an enzyme, transporter, receptor, or protein target, but rather a bioactive lipid mixture employed in complementary and alternative medicine for conditions such as osteoarthritis, rheumatoid arthritis, and other inflammatory disorders. There is no well-defined, canonical molecular target for CFAs in the sense used in drug development or pharmacology.
acts as a biolubricant, softens tissues, potentially modulates inflammatory cytokines (e.g., IL-6, TNF-α, MCP-1), stimulates chondrogenic markers in mesenchymal stem cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cetylated fatty acid (CFA).